Virbac | Sustainability Performance
Virbac SA is involved in the development and marketing of veterinary pharmaceutical products, supporting animal health and wellness across a range of species and geographical regions.
1968
France
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4457
Overallⓘ#290
in Franceⓘ#98
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Governance
TargetsFinancial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Virbac SA, French veterinary pharmaceutical company, has faced multiple US FDA Form 483 observations at its production facilities including the contested 2023 Aspart and Senergy product quality matters, plus periodic French AMF scrutiny over inadequate disclosure of veterinary pharma customer demand changes affecting share price.
